GO:0042054 histone methyltransferase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0042054 histone methyltransferase activity describes the enzymatic transfer of a methyl group from S-adenosyl-L-methionine to a histone substrate, producing S-adenosyl-L-homocysteine and methyl-histone.
• Histone methyltransferase activity can occur on arginine or lysine residues and is a core molecular function in epigenetic regulation.
• Key enzymes include EZH2, SMYD2, ASH1L, SETDB2, and Ash1, each with distinct regulatory partners and biological outputs.
• Histone methyltransferase activity influences gene expression, nuclear architecture, metabolism, vascular aging, and inflammatory responses.
• Dysregulated histone methyltransferase activity is linked to sepsis-induced acute kidney injury, abdominal aortic aneurysm, and vascular aging.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of histone methyltransferase function in disease.
Description
Histone methyltransferase activity (GO:0042054) is a molecular function that catalyzes the transfer of a methyl group from S-adenosyl-L-methionine to a histone protein, yielding S-adenosyl-L-homocysteine and methyl-histone. This activity typically modifies arginine or lysine residues on histones and is central to epigenetic regulation of chromatin structure and gene expression. Because histone methylation can mark active or repressed chromatin depending on the residue and degree of methylation, the enzymes that carry out this reaction are critical nodes in developmental, metabolic, and immune signaling. Researchers study histone methyltransferase activity to understand how cells establish and maintain transcriptional states, and to identify therapeutic targets in diseases such as sepsis-induced acute kidney injury, abdominal aortic aneurysm, and vascular aging. The activity is experimentally tractable: in vitro assays allow direct detection and quantification of methyltransferase activity, while genetic models enable causal tests of specific enzymes in cells and tissues.
histone methyltransferase activity At A Glance
| GO ID | GO:0042054 |
|---|---|
| GO term | histone methyltransferase activity |
| Ontology | molecular_function |
| Synonym | histone methylase activity; histone N-methyltransferase activity |
| Major function | Catalysis of methyl transfer from S-adenosyl-L-methionine to histone, producing S-adenosyl-L-homocysteine and methyl-histone |
| Substrate | Histone proteins, with methylation on arginine or lysine residues |
| Cofactor | S-adenosyl-L-methionine as methyl donor |
| Reaction products | S-adenosyl-L-homocysteine and methyl-histone |
| Representative enzymes | EZH2, SMYD2, ASH1L, SETDB2, Ash1 |
What Is GO:0042054?
Histone methyltransferase activity is the catalytic function defined by the reaction S-adenosyl-L-methionine + histone = S-adenosyl-L-homocysteine + methyl-histone. In other words, it is the enzyme activity that attaches a methyl group to a histone protein, using S-adenosyl-L-methionine as the methyl donor. The modification generally occurs on either an arginine or a lysine residue within the histone substrate. This activity is synonymous with histone methylase activity and histone N-methyltransferase activity.
Why Is histone methyltransferase activity Important in Cell Biology?
Histone methyltransferase activity is important because it directly controls chromatin states and gene expression programs that influence cell fate, metabolism, immune responses, and tissue homeostasis. For example, the H3K27 methyltransferase EZH2 regulates apoptotic and inflammatory responses in sepsis-induced acute kidney injury, while SMYD2 drives vascular aging through enhancer-dependent activity. Histone methyltransferase activity also programs nuclear peripheral genome positioning, linking enzymatic methylation to higher-order genome architecture. In human cells, histone methyltransferase activity can affect metabolism independently of transcriptional regulation, revealing non-canonical roles beyond gene expression. Dysregulation of these enzymes is associated with abdominal aortic aneurysm development and other disease processes, making them attractive targets for mechanistic and therapeutic studies.
• Controls epigenetic marks on histone arginine and lysine residues, influencing chromatin structure and gene expression.
• Regulates apoptotic and inflammatory responses in sepsis-induced acute kidney injury through EZH2.
• Affects cellular metabolism independently of transcriptional regulation in human cells.
• Programs nuclear peripheral genome positioning, linking methylation to genome architecture.
• Drives vascular aging via SMYD2 enhancer-dependent activity.
• Is regulated by accessory proteins such as Caf1, which senses unmodified histone H3 to control Ash1 activity.
• Can be activated by MRG15, which recruits ASH1L to nucleosomes.
• Modulates tissue inhibitors of metalloproteinase and matrix metalloproteinase activity during abdominal aortic aneurysm development via SETDB2.
• Provides a druggable molecular function for therapeutic intervention in inflammatory, vascular, and metabolic diseases.
• Can be directly detected and quantified in vitro, enabling mechanistic enzymology.
What Happens During histone methyltransferase activity?
Substrate recognition and binding
In simple terms: The enzyme first finds and grabs onto a histone protein.
Histone methyltransferase activity begins with the enzyme binding to a histone substrate, often guided by accessory factors that recognize specific chromatin states. For example, Caf1 regulates the histone methyltransferase activity of Ash1 by sensing unmodified histone H3, ensuring the enzyme acts only when the appropriate histone mark is absent. Similarly, MRG15 activates the histone methyltransferase activity of ASH1L by recruiting it to nucleosomes, illustrating that substrate recruitment is a regulated step.
Methyl group transfer from S-adenosyl-L-methionine
In simple terms: The enzyme takes a methyl group from a donor molecule and attaches it to the histone.
The catalytic step of histone methyltransferase activity transfers a methyl group from S-adenosyl-L-methionine to a histone residue, producing S-adenosyl-L-homocysteine and methyl-histone. This reaction generally occurs on either an arginine or a lysine residue within the histone substrate. In vitro detection and quantification of this activity confirm that the transfer is enzymatic and dependent on the methyl donor.
Chromatin and nuclear architecture consequences
In simple terms: The new methyl mark changes how DNA is organized inside the nucleus.
Histone methyltransferase activity can program nuclear peripheral genome positioning, meaning the methylation marks influence where chromosomes and genomic regions reside within the nucleus. This links the enzymatic reaction to higher-order genome organization and suggests that histone methylation is not only a local chromatin mark but also a determinant of nuclear architecture.
Metabolic and transcriptional outputs
In simple terms: The methyl mark can change cell metabolism even without changing gene expression.
Histone methyltransferase activity affects metabolism in human cells independently of transcriptional regulation, indicating that the function can directly influence metabolic pathways. In parallel, specific enzymes such as EZH2 regulate apoptotic and inflammatory responses in sepsis-induced acute kidney injury, showing that histone methyltransferase activity can drive disease-relevant transcriptional and inflammatory programs. SMYD2 drives vascular aging by its enhancer-dependent activity, further demonstrating that the consequences of histone methylation are context-dependent.
Key Genes Involved in GO:0042054 histone methyltransferase activity
The following genes encode enzymes or regulators with demonstrated roles in histone methyltransferase activity (GO:0042054) and its biological outputs.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EZH2 | H3K27 methyltransferase | Regulates apoptotic and inflammatory responses in sepsis-induced acute kidney injury |
| SMYD2 | Histone methyltransferase | Drives vascular aging via enhancer-dependent activity |
| ASH1L | Histone methyltransferase | Activated by MRG15, which recruits it to nucleosomes |
| SETDB2 | Histone methyltransferase | Modulates TIMP-MMP activity during abdominal aortic aneurysm development |
| Ash1 | Histone methyltransferase | Regulated by Caf1, which senses unmodified histone H3 |
| MRG15 | Activator/recruiter | Activates ASH1L histone methyltransferase activity by recruiting it to nucleosomes |
| Caf1 | Regulator | Regulates Ash1 histone methyltransferase activity by sensing unmodified histone H3 |
| H3 | Histone substrate | Substrate for methylation on arginine or lysine residues |
| H4 | Histone substrate | Substrate for methylation on arginine or lysine residues |
| SET domain proteins | Catalytic domain family | Common catalytic module for histone methyltransferase activity |
| S-adenosyl-L-methionine | Methyl donor | Cofactor supplying the methyl group for the reaction |
| S-adenosyl-L-homocysteine | Reaction product | Product of methyl transfer from S-adenosyl-L-methionine |
| Methyl-histone | Reaction product | Modified histone carrying the transferred methyl group |
| TIMP | Downstream effector | Modulated by SETDB2 during abdominal aortic aneurysm development |
| MMP | Downstream effector | Modulated by SETDB2 during abdominal aortic aneurysm development |
| Nuclear periphery | Structural target | Programmed by histone methyltransferase activity |
| Metabolic pathways | Functional output | Affected by histone methyltransferase activity independently of transcription |
How Is histone methyltransferase activity Regulated?
Histone methyltransferase activity is regulated at multiple levels. Accessory proteins can directly control enzyme activity: Caf1 regulates the histone methyltransferase activity of Ash1 by sensing unmodified histone H3, ensuring context-dependent catalysis. MRG15 activates the histone methyltransferase activity of ASH1L by recruiting it to nucleosomes, demonstrating that recruitment is a key regulatory mechanism. In addition, the activity can be influenced by the chromatin environment and by the availability of histone substrates, as the reaction requires a histone substrate and S-adenosyl-L-methionine as a methyl donor. Disease-associated regulation includes enhancer-dependent activity of SMYD2 in vascular aging, indicating that regulatory elements can shape the functional output of histone methyltransferase activity.
histone methyltransferase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EZH2 | Sepsis-induced acute kidney injury | Knockout or overexpression in kidney cell lines and animal models |
| SMYD2 | Vascular aging | Enhancer-dependent overexpression or point-mutation models in vascular cells |
| SETDB2 | Abdominal aortic aneurysm | Knockout or knockdown in vascular smooth muscle cells and aneurysm models |
| ASH1L | Chromatin regulation via MRG15 | Knock-in of tagged ASH1L for recruitment studies |
| Ash1 | Histone H3 sensing by Caf1 | Point-mutation models to disrupt Caf1-Ash1 interaction |
Sepsis-induced acute kidney injury
The histone H3K27 methyltransferase EZH2 regulates apoptotic and inflammatory responses in sepsis-induced acute kidney injury, linking histone methyltransferase activity to inflammatory tissue injury. This suggests that modulating EZH2 activity could influence apoptotic and inflammatory outcomes in sepsis-associated kidney damage.
Vascular aging and abdominal aortic aneurysm
Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity, implicating histone methylation in age-related vascular dysfunction. Separately, the histone methyltransferase SETDB2 modulates tissue inhibitors of metalloproteinase and matrix metalloproteinase activity during abdominal aortic aneurysm development, connecting histone methyltransferase activity to extracellular matrix remodeling in vascular disease.
Metabolic and nuclear architecture phenotypes
Histone methyltransferase activity affects metabolism in human cells independently of transcriptional regulation, suggesting that metabolic diseases may involve non-transcriptional consequences of histone methylation. Histone methyltransferase activity also programs nuclear peripheral genome positioning, which may contribute to disease-associated changes in nuclear organization.
From histone methyltransferase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of EZH2 methyltransferase activity alter apoptotic and inflammatory responses? | EZH2 knockout cell lines and sepsis-induced acute kidney injury models |
| Does SMYD2 enhancer-dependent activity drive vascular aging? | SMYD2 overexpression and enhancer-mutant knock-in models |
| How does Caf1 sense unmodified histone H3 to regulate Ash1? | Point-mutation knock-in of Ash1 or Caf1 interaction interfaces |
| How does MRG15 recruit ASH1L to nucleosomes? | Tagged knock-in of ASH1L and MRG15 for recruitment assays |
| Does SETDB2 modulate TIMP-MMP activity during abdominal aortic aneurysm? | SETDB2 knockout or overexpression in vascular cells and aneurysm models |
| Does histone methyltransferase activity affect metabolism independently of transcription? | Overexpression and catalytic-dead point-mutation models in human cells |
How to Study the histone methyltransferase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| In vitro methyltransferase assay | Transfer of methyl group from S-adenosyl-L-methionine to histone | Detection and quantification of histone methyltransferase activity |
| CRISPR knockout | Loss of enzyme function | Testing causal roles of EZH2, SETDB2, or SMYD2 in disease models |
| CRISPR point mutation | Specific catalytic or interaction residue changes | Dissecting Caf1-Ash1 sensing or catalytic-dead variants |
| CRISPR knock-in | Tagged or mutant enzyme expression | Recruitment studies of ASH1L by MRG15 |
| Overexpression | Gain of enzyme activity | Modeling SMYD2-driven vascular aging or EZH2 inflammatory effects |
| Imaging | Nuclear peripheral genome positioning | Linking histone methyltransferase activity to nuclear architecture |
| Metabolic profiling | Metabolic pathway changes | Detecting transcription-independent effects of histone methyltransferase activity |
| Transcriptional profiling | Gene expression programs | Identifying apoptotic, inflammatory, and vascular targets |
In vitro histone methyltransferase activity assays
Detection and quantification of histone methyltransferase activity in vitro allows direct measurement of methyl transfer from S-adenosyl-L-methionine to histone substrates. These assays are foundational for confirming that a candidate enzyme possesses histone methyltransferase activity and for testing regulatory partners such as Caf1 and MRG15.
Genetic perturbation with CRISPR
CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal tests of specific histone methyltransferase genes in disease contexts. For example, EZH2 knockout or overexpression can reveal effects on apoptotic and inflammatory responses in sepsis-induced acute kidney injury, while SMYD2 enhancer-dependent activity can be dissected with targeted knock-in or overexpression.
Chromatin and nuclear architecture imaging
Imaging approaches can assess nuclear peripheral genome positioning, which is programmed by histone methyltransferase activity. Combining imaging with genetic perturbation allows researchers to link specific enzymes to changes in nuclear architecture.
Metabolic and transcriptional profiling
Metabolic profiling can reveal effects of histone methyltransferase activity that occur independently of transcriptional regulation. Transcriptional profiling complements these measurements by identifying apoptotic, inflammatory, and vascular gene programs controlled by enzymes such as EZH2, SMYD2, and SETDB2.
How CRISPR Can Be Used to Study GO:0042054 histone methyltransferase activity
Knockout
CRISPR knockout of histone methyltransferase genes such as EZH2, SETDB2, or SMYD2 removes enzymatic activity and allows researchers to test loss-of-function phenotypes in disease models. For example, EZH2 knockout can reveal effects on apoptotic and inflammatory responses in sepsis-induced acute kidney injury, and SETDB2 knockout can test modulation of TIMP-MMP activity during abdominal aortic aneurysm development.
Point Mutation
CRISPR point mutation can introduce catalytic-dead or interaction-disrupting substitutions in histone methyltransferase genes, enabling separation of enzymatic activity from scaffolding functions. This is particularly useful for studying regulatory interfaces such as the Caf1-Ash1 interaction that senses unmodified histone H3.
Knock-in
CRISPR knock-in of tags or disease-relevant alleles allows tracking and functional analysis of histone methyltransferases in their native context. Tagged knock-in of ASH1L, for instance, supports studies of how MRG15 recruits it to nucleosomes to activate its histone methyltransferase activity.
Overexpression
CRISPR-mediated overexpression or cDNA-based overexpression can model gain-of-function states of histone methyltransferases such as SMYD2 in vascular aging or EZH2 in inflammatory injury. Overexpression combined with metabolic profiling can also test transcription-independent effects of histone methyltransferase activity.
How EDITGENE Supports histone methyltransferase activity Research
Researchers studying histone methyltransferase activity-related genes often need to determine whether a candidate gene is causally involved in a specific disease or cellular process, and which enzymatic functions are required. This requires precise genetic models that can remove, modify, or add histone methyltransferase activity in relevant cell types. EDITGENE provides end-to-end CRISPR services to generate such models and to interpret the resulting phenotypes with bioinformatics support.
Contact EDITGENE today to design your custom CRISPR model for histone methyltransferase activity research.
Frequently Asked Questions About histone methyltransferase activity
What is histone methyltransferase activity?
Histone methyltransferase activity (GO:0042054) is the catalysis of the reaction S-adenosyl-L-methionine + histone = S-adenosyl-L-homocysteine + methyl-histone, generally on an arginine or lysine residue.
What genes are involved in histone methyltransferase activity?
Key genes include EZH2, SMYD2, ASH1L, SETDB2, and Ash1, along with regulators such as MRG15 and Caf1.
What is the GO ID for histone methyltransferase activity?
The GO ID is GO:0042054, under the molecular_function ontology.
How is histone methyltransferase activity detected?
It can be detected and quantified in vitro by measuring methyl transfer from S-adenosyl-L-methionine to histone substrates.
Does histone methyltransferase activity affect metabolism?
Yes, histone methyltransferase activity affects metabolism in human cells independently of transcriptional regulation.
How does EZH2 histone methyltransferase activity affect kidney injury?
EZH2 regulates apoptotic and inflammatory responses in sepsis-induced acute kidney injury.
What role does SMYD2 histone methyltransferase activity play in vascular aging?
SMYD2 drives vascular aging by its enhancer-dependent activity.
How is Ash1 histone methyltransferase activity regulated?
Caf1 regulates the histone methyltransferase activity of Ash1 by sensing unmodified histone H3.
How does MRG15 activate ASH1L?
MRG15 activates histone methyltransferase activity of ASH1L by recruiting it to the nucleosomes.
What is the link between SETDB2 and abdominal aortic aneurysm?
SETDB2 modulates tissue inhibitors of metalloproteinase and matrix metalloproteinase activity during abdominal aortic aneurysm development.
Conclusion
Histone methyltransferase activity (GO:0042054) is a central molecular function that transfers methyl groups from S-adenosyl-L-methionine to histone arginine or lysine residues, producing methyl-histone and influencing chromatin, transcription, metabolism, and nuclear architecture. Its dysregulation is implicated in sepsis-induced acute kidney injury, vascular aging, and abdominal aortic aneurysm, with enzymes such as EZH2, SMYD2, ASH1L, SETDB2, and Ash1 as key players. Continued research using in vitro assays and CRISPR-based genetic models will clarify how specific histone methyltransferases contribute to disease and whether their activity can be targeted therapeutically.
References
- 1. Li B et al.. 2023. Histone H3K27 methyltransferase EZH2 regulates apoptotic and inflammatory responses in sepsis-induced AKI.. Theranostics 13(6):1860-1875 PMID: 37064878
- 2. Perez MF et al.. 2023. Histone methyltransferase activity affects metabolism in human cells independently of transcriptional regulation.. PLoS Biol 21(10):e3002354 PMID: 37883365
- 3. See K et al.. 2020. Histone methyltransferase activity programs nuclear peripheral genome positioning.. Dev Biol 466(1-2):90-98 PMID: 32712024
- 4. Su Z et al.. 2022. Histone methyltransferase Smyd2 drives vascular aging by its enhancer-dependent activity.. Aging (Albany NY) 15(1):70-91 PMID: 36585926
- 5. Yoon E et al.. 2023. Caf1 regulates the histone methyltransferase activity of Ash1 by sensing unmodified histone H3.. Epigenetics Chromatin 16(1):15 PMID: 37118845
- 6. Idigo NJ et al.. 2022. Detection and Quantification of Histone Methyltransferase Activity In Vitro.. Methods Mol Biol 2529:43-61 PMID: 35733009
- 7. Al-Harthi S et al.. 2023. MRG15 activates histone methyltransferase activity of ASH1L by recruiting it to the nucleosomes.. Structure 31(10):1200-1207.e5 PMID: 37527654
- 8. Davis FM et al.. 2023. The Histone Methyltransferase SETDB2 Modulates Tissue Inhibitors of Metalloproteinase-Matrix Metalloproteinase Activity During Abdominal Aortic Aneurysm Development.. Ann Surg 278(3):426-440 PMID: 37325923
